Opocrin has acquired 1 company, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms.
The Company’s most targeted sectors include life science (100%).
Strada Scaglia Est n. 5,
Modena,
41126
Italy,
www.opocrin.it
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-04-29 |
LDO S.p.A. (Laboratori Derivati Organici) · Life Science
Trino, Italy · www.ldospa.com LDO S.p.A. (Laboratori Derivati Organici) has focussed its manufacturing activities on the extraction of active pharmaceutical ingredients from animal organs, specializing in the manufacture of heparin and its derivatives. Its expertise in the extraction and purification of APIs, accrued over decades of manufacture and research, has made LDO a leading manufacturer of Glycosaminoglycans, and it now exports its products to customers worldwide, from multinational corporations to small local businesses in the pharmaceutical, cosmetics and nutrition sectors. LDO was formed in 1960 and is based in Trino, Italy. |
- | Add-on Acquisition |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
